SCHEMBL32662573

SCHEMBL32662573

CN1c2ccccc2SC1O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 1/20 0.43
▸ NOX1 Q9Y5S8 2/20 0.37
▸ BCHE P06276 8/20 0.37
▸ ALDH1A1 P00352 2/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ GSK3B P49841 1/20 0.36
▸ MAPT P10636 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ ACHE P22303 2/20 0.34
▸ KDM1A O60341 1/20 0.34
▸ PTGS1 P23219 1/20 0.34
▸ PTGS2 P35354 1/20 0.34
▸ MEN1 O00255 1/20 0.33
▸ ADRA2A P08913 1/20 0.33
▸ ADRA2B P18089 1/20 0.33
▸ ADRA2C P18825 1/20 0.33
▸ CHRM3 P20309 1/20 0.33
▸ SLC6A2 P23975 1/20 0.33
▸ HTR2C P28335 1/20 0.33
▸ SLC6A4 P31645 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12264201 0.78 MAOA (0.46) MAOANOX1BCHEALDH1A1SMN1; SMN2
SCHEMBL347425 0.77 MAOA (0.45) MAOANOX1BCHEALDH1A1SMN1; SMN2
SCHEMBL28714775 0.77 BCHE (0.36) MAOANOX1BCHEGSK3BACHE
SCHEMBL29814962 0.77 MAOA (0.45) MAOANOX1BCHEALDH1A1SMN1; SMN2
SCHEMBL16728889 0.77 MAOA (0.45) MAOANOX1BCHEALDH1A1SMN1; SMN2
SCHEMBL1156077 0.75 MAOA (0.43) MAOANOX1BCHEALDH1A1SMN1; SMN2
SCHEMBL31571121 0.75 MAOA (0.43) MAOANOX1BCHEALDH1A1SMN1; SMN2
SCHEMBL7138108 0.75 MAOA (0.43) MAOANOX1BCHEALDH1A1SMN1; SMN2
SCHEMBL1412732 0.75 MAOA (0.43) MAOANOX1ALDH1A1SMN1; SMN2GSK3B
SCHEMBL4580436 0.75 MAOA (0.43) MAOANOX1BCHEALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260015321-A1 CHEMICAL COMPOUNDS AND USES THEREOF GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.4) LIMITED (GB) 2026-01-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260015321-A1 CHEMICAL COMPOUNDS AND USES THEREOF WRN, MSH2, MSH6 MAOA 2427/4885NOX1 4386/4885BCHE 3848/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback